Cencora, Inc. COR NYSE

NYSE • Healthcare • Medical - Distribution • US • USD

SharesGrow Score

53/100

2/7 Pass

SharesGrow Intrinsic Value

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Cencora, Inc. (COR) reported total assets of $76.59B and total liabilities of $74.84B for fiscal year 2025, resulting in total equity of $1.75B.

The company held $4.39B in cash and short-term investments. Total debt stood at $10.75B, with net debt of $6.35B. The Debt-to-Equity (D/E) ratio was 6.15 (leveraged).

Current ratio is 0.9, which may signal tight short-term liquidity. Interest coverage is 8.7x (strong).

Criteria supported by this page:

HEALTH (33/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
MOAT (49/100) — Total assets $76.59B and equity $1.75B support the company's competitive scale
VALUE (32/100) — Debt-to-Equity 6.15 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 53/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score

53/100

SG Score

View full scorecard →

✗

VALUE

32/100

Price-to-Earnings & upside

→ Valuation

✓

FUTURE

79/100

Analyst consensus

→ Forecast

✓

PAST

100/100

→ Income

✗

HEALTH

33/100

Debt-to-Equity & liquidity

Proven by this page

MOAT

49/100

→ Income

GROWTH

48/100

→ Income

✗

INCOME

30/100

→ Income

Cencora, Inc. Balance Sheet History

Metric	FY2025	FY2024	FY2023	FY2022
Total Assets	$76.59B	$67.1B	$62.56B	$56.56B
Total Liabilities	$74.84B	$66.31B	$61.89B	$56.49B
Total Debt	$10.75B	$4.39B	$4.79B	$5.7B
Cash & Investments	$4.39B	$3.13B	$2.59B	$3.39B
Total Stockholders Equity	$1.51B	$645.94M	$666.29M	$-289.78M